Zacks Investment Research
06 Aug 2026, 14:51 UTC · 14w ago
Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates
Impact · against what's priced in
Cresco Labs (CRLBF) shows a positive shift toward profitability with a Q2 EPS beat ($0.04 vs -$0.02 estimate) and steady revenue growth. While the quarterly results are strong, they combat a severe year-to-date price decline of 46.6%, suggesting the market has been pricing in systemic instability.
- CRLBF+0.30
No priced-in read yet
- In context
The company shifted from a projected loss of $0.02 per share to a profit of $0.04 per share, while revenues of $173.34 million beat estimates by 4.41%.
Read from the article alone
Top 1 mover · tap to explore
